West Pharmaceutical Services files SEC Form 8-K Item 1.05, data exfiltrated, systems encrypted, global operations partially restarted

West Pharmaceutical Services Inc. (NYSE: WST), a US-headquartered global manufacturer of drug-delivery and packaging components, filed a Form 8-K on 2026-05-11 disclosing a material cybersecurity incident under Item 1.05 (SEC EDGAR, WST 8-K, 2026-05-11). The filing states that detection occurred on May 4 2026, materiality was determined May 7, and that "certain data was exfiltrated by an unauthorized party and certain systems were encrypted", terminology consistent with a T1486 Data Encrypted for Impact plus T1041 Exfiltration Over C2 Channel double-extortion ransomware pattern. The company took global systems offline, activated incident response, notified law enforcement and engaged external forensics; core enterprise systems are restored, shipping/receiving/manufacturing are partially restarted at some facilities, and full restoration timeline and material financial impact remain undetermined. No threat actor has claimed responsibility publicly at time of filing.